← FDA DRUG APPROVALS

FDA ANDA · ANDA074623

LACTULOSE

Sponsor: PHARM ASSOC

APPLICATION
ANDA074623
TYPE
ANDA
ORIGINAL APPROVAL
1996-07-30
LATEST ACTION
2020-03-24
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LACTULOSEPrescription
LACTULOSE 10GM/15ML · SOLUTION · ORAL

Approval history

2020-03-24Labeling · Supplement 12 · standardAP
2020-03-24Labeling · Supplement 10 · standardAP
2020-03-24Labeling · Supplement 11 · standardAP
1996-07-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →